Human papilloma virus anti-sense oligonucleotides

Details Human papilloma virus anti-sense oligonucleotides Human papilloma virus anti-sense oligonucleotides

1997-09-05

2000-07-04

Schwartzman, Robert A.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

435 6, 536 241, C07H 2104

Patent

active

060840900

ABSTRACT:
Antisense oligonucleotides having phosphorothioate backbone structure and sequences complementary to nucleotides contained with residues 415 to 445 of human papilloma virus 16 (HPV-16) are disclosed. Methods of treatment using antisense oligonucleotides having phosphorothioate backbone structure and nucleotide sequences complementary to nucleotides contained with residues 415 to 445 of HPV-16 are disclosed.

REFERENCES:
patent: 5683902 (1997-11-01), Harper et al.
Stull et al "Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress & Prospects." Pharmaceutical Research vol. 12 (4) 465-483, 1995.
Uhrman et al "Antisense Oligonucleotides: A New Therapeutic Principle". Chemical Reviews vol. 90(4) 543-584, 1990.
Agrawal, et al., Synthesis and Anti-HIV Activity of Oligorbonucleotides and Their Phosphorothioate . . . , Ann. New York Acad. Sci. 660:2-10 (1992).
Agrawal, S., Antisense oligonucleotides: towards clinical trials, TIBTECH 14:3-14 (1996).
Agrawal, et al., Mixed-backbone oligonucleotides as second generation antisense . . . , Proc. Natl. Acad. Sci. USA 94:2620-2625 (1997).
Alvarez-Salas, et al., Transcriptional repression in normal human keratinocytes by wild-type . . . , Cancer Lett. 91:85-92 (1995).
Anderson, et al., Mutagenesis of the hairpin ribozyme, Nucl. Acids Res. 22(6) :1096-1100 (1994).
Cech, T.R., Ribozymes and Their Medical Implications, JAMA 260(20): 3030-3034 (1988).
Chen, et al., Synthesis of oligodeoxyribonucleotide N3-P5 phosphoramidates, Nucl. Acids Res. 23(14) :2661-2668 (1995).
Cohen, J.S., Informational Drugs: A New Concept in Pharmacology, Antisense Res. Dev. 1:191-193 (1991).
Dagle, et al., Physical properties of oligonucleotides containing phosphoramidate-modified . . . , Nucl. Acids Res. 19(8):1805-1810 (1991).
DiPaolo, et al., Cellular and Molecular Alterations in Human Epithelial Cells Transformed . . . , Crit. Rev. Oncogen. 4(4):337-360 (1993).
EsCude, et al., Stable triple helices formed by oligonucleotide N3-P5 phosphoramidates . . . , Proc. Natl. Acad. Sci. USA 93(9) 4365-4369 (1996).
Froehler, et al., Phosphoramidate analogues of DNA: synthesis and thermal stability of heteroduplexes . . . , Nucl. Acids Res. 16(11):4831-4839 (1988).
Gryaznov, et al., Oligonucleotide N3-P5 phosphoramidates as antisense agents, Nucl. Acids Res. 24(8):1508-1514 (1996).
Hamada, et al., Adenovirus-Mediated Transfer of HPV 16 E6/E7 Antisense RNA to Human Cervical Cancer Cells, Gynecol. Oncol. 63:219-227 (1996).
Hampel, et al., RNA Catalytic Properties of the Minimum (-) sTRSV Sequence, Biochem. 28:4929-4933 (1989).
Hampel, et al., "Hairpin" catalytic RNA model: evidence for helices and sequence requirement for . . . , Nucl. Acids Res. 18(2):299-304 (1990).
Haseloff, et al., Sequences required for self-catalysed cleavage of the satellite RNA of tobacco . . . , Gene 82:43-52 (1989).
Hawley-Nelson, et al., HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes, EMBO J. 8(12):3905-3910 (1989).
Henry, et al., Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate . . . , Toxicol. 116:77-88 (1997).
Henry, et al., Toxicological properties of several novel oligonucleotide analogs in mice, Anticancer Drug Des. 12:1-14 (1997).
Kean, et al., Inhibition of Herpes simplex virus Replication by Antisense Oligo-2-O-methylribonucleoside . . . , Biochem. 34(45):14617-14620 (1995).
Marshall, et al., Inhibition of human immunodeficiency virus activity by phosphorodithioate . . . , Proc. Natl. Acad. Sci. USA 89:6265-6269 (1992).
McKay, et al., Enhanced activity of an antisense oligonucleotide targeting murine protein kinase . . . , Nucl. Acids Res. 24(3):411-417 (1996).
Metelev, et al., Study of Antisense Oligonucleotide Phosphorothioates Containing Segments . . . , Bioorg. Med. Chem. Lett. 4(24):2929-2934 (1994).
Miller et al., Anticode Oligonucleoside Methylphosphonates and Their Psoralen Derivatives, Antisense Res. and Appl. pp. 189-203 (1993).
Monia, et al., Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide . . . , Nature Medicine 2(6):668-675 (1996).
Monia, et al., Evaluation of 2-Modified Oligonucleotides Containing 2-Deoxy Gaps . . . , J. Biol. Chem. 268(19):14514-14522 (1993).
Ojwang, et al., Inhibition of human immunodeficiency virus type 1 expression by . . . , Proc. Natl. Acad. Sci. USA 89:10802-10806 (1992).
Phelps, et al., The Human Papillomavirus Type 16 E7 Gene Encodes Transactivation . . . , Cell 53:539-547 (1988).
Pirisi, et al., Continuous cell lines with altered growth and differentiation . . . , Carcinogen. 9(9):1573-1579 (1988).
Roush, W., Antisense Aims for a Renaissance, Science 276:1192-1193 (1997).
Sarin, et al., Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside . . . , Proc. Natl. Acad. Sci. USA 85:7448-7451 (1988).
Scheffner, et al., The E6 Oncoprotein Encoded by Human Papillomavirus Types 16 and 18 . . . , Cell 63:1129-1136 (1990).
Schiffman, et al., New Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia, J. Natl. Cancer Inst. 87(18):1345-1347 (1995).
Skorski, et al., Antileukemia efect of c-myc N3-P5 phosphoramidate antisense . . . , Proc. Natl. Acad. Sci. USA 94:3966-3971 (1997).
Steele, et al., Effects of Human Papillomavirus Type 18-specific Antisense Oligonucleotides on the Transformed . . . , Cancer Res. 53:2330-2337 (1993).
Storey, et al., Anti-sense phosphorothioate oligonucleotides have both specific and non-specific . . . , Nucl. Acids Res. 19(15):6209-6224 (1987).
Tanaka, et al., Synthesis of oligodeoxyribonucleotide with aliphatic amino or phosphate group at the 5 . . . , Nucl. Acids Res. 19(15):6209-6224 (1987).
Viallet, et al., Characterization of Human Bronchial Epithelial Cells Immortalized by the . . . , Exp. Cell Res. 212:36-41 (1994).
von Knebel Doeberitz, et al. Analysis of the Biological Role of Human Papiilloma Virus (HPV) . . . , Hamatol. Bluttransfus. 31:377-279 (1987).
Walder, J., Antisense DNA and RNA: progress and prospects, Genes Dev. 2:502-504 (1988).
Yokoyama, et al., Human Papillomavirus 18-Immortalized Endocervical Cells With In Vitro Cytokeratin . . . , Obstet. Gynecol. 83(2):197-204 (1994).
Yu, et al., A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency . . . , Proc. Natl. Acad. Sci. USA 90:6340-6344 (1993).
Zerfass, et al., Sequential Activation of Cyclin E and Cyclin A Gene Expression by Human . . . , J. Virol. 69(10):6389-6399 (1995).
zur Hausen, et al., Human Papillomaviruses, Annu. Rev. Microbiol. 48:427-447 (1994).

Affiliated with

Also associated with

Rating

Human papilloma virus anti-sense oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human papilloma virus anti-sense oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human papilloma virus anti-sense oligonucleotides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1487692